This product is not intended for human or animal consumption, diagnosis, or treatment
Regulatory Status and Safety Takeaway FDA Status: IGF-1 LR3 is not approved by the FDA for human therapeutic use and is highly restricted
APOE genotype with a focus on the cerebrovasculature is important due to its crucial role in delivering nutrients from the periphery to the brain
Candidacy depends on your goals, your skin and hair concerns, your medical history, and any medications or conditions that could interact with a peptide protocol
Yes, the FDA has approved semaglutide (Wegovy) and liraglutide (Saxenda) for adolescents aged 12 years and older who have a BMI at or above the 95th percentile for their age and sex
Before starting any new therapy, always be sure a healthcare practitioner provides direction suitable for your skin type and condition